I think SI is more than happy to conduct the extension trial together with the FDA.
Yes. As mentioned in this morning's phone conference, MSB will conduct an adult RCT against the current best treatment available (i.e. ruxolitinib). This is going to hurt the competition some more.
- Forums
- ASX - By Stock
- MSB
- Ryoncil: ODAC/FDA Meeting Discussion
Ryoncil: ODAC/FDA Meeting Discussion, page-1994
-
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.02 |
Change
-0.050(4.67%) |
Mkt cap ! $1.221B |
Open | High | Low | Value | Volume |
$1.05 | $1.05 | $1.02 | $2.054M | 1.988M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 131630 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 27203 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 117659 | 1.020 |
18 | 194199 | 1.015 |
28 | 199252 | 1.010 |
15 | 811648 | 1.005 |
26 | 368952 | 1.000 |
Price($) | Vol. | No. |
---|---|---|
1.025 | 47392 | 6 |
1.030 | 197795 | 18 |
1.035 | 157753 | 8 |
1.040 | 86176 | 9 |
1.045 | 104509 | 8 |
Last trade - 10.32am 30/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online